// App-Quantinova.ai

e15080 : Efficacy and safety profile of PD-1 and pdl-1 inhibitors in African American patients.

Researchers

Presenter

  • Shahla Bari

Principal Investigators

  • Sanjay R Jain

  • Rathi Narayana Pillai

Medical Centers

  • Morehouse School of Medicine, Atlanta, GA

  • Winship Cancer Institute of Emory University, Atlanta, GA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Programmed cell death protein 1

  • Programmed death-ligand 1

Drug/Treatment

  • Pembrolizumab

  • Atezolizumab

  • Durvalumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved